20 LATEST RESOURCES (153 INDEXED)
The Efficacy and Safety of Sodium Nitroprusside in the Treatment of Schizophrenia: A Meta-Analysis · November 2023
Articles
Frontiers in Psychiatry
Oxytocin as a Treatment for High-Risk Psychosis or Early Stages of Psychosis: A Mini Review · August 2023
Articles
Frontiers in Psychiatry
Psychiatric Adverse Reaction to COVID-19 Vaccine Booster Presenting as First-Episode Acute Mania with Psychotic Features: A Case Report · July 2023
Articles
Psychiatry Research Case Reports
Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder · May 2023
Articles
Clinical Psychopharmacology and Neuroscience
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions · May 2023
Articles
Neuropsychiatric Disease and Treatment
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
Glucagon-Like Peptide-1 Receptor-Agonists Treatment for Cardio-Metabolic Parameters in Schizophrenia Patients: A Systematic Review and Meta-Analysis · May 2023
Articles
Frontiers in Psychiatry
Antiviral Treatment in Schizophrenia: A Randomized Pilot PET Study on the Effects of Valaciclovir on Neuroinflammation · April 2023
Articles
Psychological Medicine
Clonidine Augmentation in Patients with Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial · March 2023
Articles
Schizophrenia Research
Ribavirin Treatment for Severe Schizophrenia with Anti-Borna Disease Virus 1 Antibodies 30 Years After Onset · February 2023
Articles
Case Reports in Psychiatry
A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia · February 2023
Articles
Brain Sciences
Psychiatric and Non-Psychiatric Polypharmacy among Older Adults with Schizophrenia: Trends from a Population-Based Study between 2000 and 2016 · February 2023
Articles
Frontiers in Pharmacology
Time-to-Therapy Discontinuation in Patients Newly Diagnosed with Schizophrenia Initiated on Long-Acting Injectable versus Oral Dopamine Receptor Blocking Agents · January 2023
Articles
Early Intervention in Psychiatry
Rituximab as an Adjunctive Treatment for Schizophrenia Spectrum Disorder or Obsessive-Compulsive Disorder: Two Open-Label Pilot Studies on Treatment-Resistant Patients · December 2022
Articles
Journal of Psychiatric Research
Severe Maniform Psychosis Induced by Corticosteroids in a Patient with Acute Lymphoblastic Leukemia, a Case Report · December 2022
Articles
Psychiatry Research Case Reports
Pimavanserin Exposure-Response Analyses in Patients with Schizophrenia: Results from the Phase 2 ADVANCE Study · November 2022
Articles
Journal of Clinical Psychopharmacology
Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19 · November 2022
Articles
Primary Care Companion for CNS Disorders
Bidirectionality of Antiseizure and Antipsychotic Treatment: A Population-Based Study · September 2022
Articles
Epilepsy and Behavior
Esketamine for Unipolar Major Depression with Psychotic Features: A Retrospective Chart Review and Comparison with Nonpsychotic Depression · July 2022
Abstracts
Journal of Clinical Psychopharmacology